Drugmakers Want Zetia 'Shortcut' Cert. Short-Circuited
A Virginia federal judge improperly certified a wildly atypical class last month when she recognized Zetia direct buyers accusing Merck and Glenmark Pharmaceuticals of conspiring to keep a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article